Close

AVII Cash Flow Statement

Click line-items for a historical chart and %
Net income (loss) and comprehensive income (loss) -908K
Depreciation and amortization 763K
Loss on disposal of assets 161K
Realized gain on sale of short-term securities-available-for-sale 0
Write-down of short-term securities-available-for-sale 0
Impairment charge on real estate owned 109K
Stock-based compensation 2.45M
Conversion of interest accrued to common stock 0
Acquired in-process research and development 0
Increase (decrease) on warrant valuation -25.58M
Accounts receivable and other current assets -1.36M
Net increase in accounts payable, accrued employee compensation, and other liabilities 6.33M
Net cash used in operating activities -18.03M
Purchase of property and equipment -973K
Patent costs -548K
Purchase of marketable securities 0
Sale of marketable securities 0
Acquisition costs 0
Net cash used in investing activities -1.52M
Proceeds from sale of common stock, warrants, and partnership units, net of offering costs, and exercise of options and warrants 32.38M
Repayments of long-term debt -61K
Buyback of common stock pursuant to rescission offering 0
Withdrawal of partnership net assets 0
Issuance of convertible debt 0
Net cash provided by (used in) financing activities 32.32M
Increase (decrease) in cash and cash equivalents 12.77M
Beginning of period 33.59M
End of period 46.36M
Cash paid during the year for interest 68K
Short-term securities-available-for-sale received in connection with the private offering 0
Issuance of common stock and warrants in satisfaction of liabilities 643K
Issuance of common stock for building purchase 0
Assumption of long-term debt for building purchase 0
Issuance of common stock for Ercole assets 0
Assumption of liabilities for Ercole assets 0

Entities mentioned with AVII

View All Entities